Form 4 for RCEL AVITA Medical, Inc.
Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071252 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-27 | 2021-12-22 | RCEL | CORBETT JAMES | Dir | A - Grant | — | +13.0K | 13.0K | New | — |
| DM | 2021-12-27 | 2021-12-22 | RCEL | CORBETT JAMES | Dir | A - Grant | $0.00 | +7,475 | 2,550 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-22 | A | A | 8,675 | — | 8,675 | D | — | — | (F1) Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date. (F2) Includes unvested RSUs. |
| 2 | Common | Common Stock | 2021-12-22 | A | A | 4,350 | — | 13,025 | D | — | — | (F3) Represents an award of RSUs that vest on the date 12 months following the grant date. (F2) Includes unvested RSUs. |
| 3 | Derivative | Stock Options (Right to Buy) | 2021-12-22 | A | A | 4,925 | $0.00 | 4,925 | D | $12.18 · — to 2031-12-22 | 4,925 Common Stock | (F4) These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date. |
| 4 | Derivative | Stock Options (Right to Buy) | 2021-12-22 | A | A | 2,550 | $0.00 | 2,550 | D | $12.18 · — to 2031-12-22 | 2,550 Common Stock | (F5) These Stock Options vest on the date 12 months following the grant date. |